Alice H Berger

ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 11

Top Venues

Fred Hutchinson Cancer Research Center

Weill Cornell Graduate School of Medical Sciences (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fred Hutchinson Cancer Research Center Sep 01 2016

United States

Assistant Member :: Human Biology

Dana Farber Cancer Institute

United States

Postdoctoral Fellow :: Medical Oncology

Education History

Weill Cornell Graduate School of Medical Sciences

United States

PHD

University of Virginia

United States

BSC

Publications

Sitapriya Moorthi, Alice H Berger
All About That Ras: Novel Fusion Drives Ras Pathway Activation in Lung Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (14) (2022)
April Lo, Maria McSharry, Alice H Berger
Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer. BMC cancer 22 (1) (2022)
Oana Ursu, James T Neal, Emily K Shea, Pratiksha I Thakore, Livnat Jerby, Lan Nguyen, Danielle Dionne, Celeste Diaz, Julia Bauman, Mariam Mounir Mosaad, Christian Fagre, April Lo, Maria McSharry, Andrew O Giacomelli, Seav Huong Ly, Orit Rozenblatt-Rosen, William C Hahn, Andrew J Aguirre, Alice H Berger, Aviv Regev, Jesse S Boehm
Massively parallel phenotyping of coding variants in cancer with Perturb-seq. Nature biotechnology 40 (6) (2022)
April Lo, Maria McSharry, Alice H Berger
Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer. BMC cancer 22 (1) (2022)
April Lo, Maria McSharry, Alice H Berger
Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer. BMC cancer 22 (1) (2022)
April Lo, Maria McSharry, Alice H Berger
Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer. BMC cancer 22 (1) (2022)
Athea Vichas, Amanda K Riley, Naomi T Nkinsi, Shriya Kamlapurkar, Pheobe C R Parrish, April Lo, Fujiko Duke, Jennifer Chen, Iris Fung, Jacqueline Watson, Matthew G Rees, Austin M Gabel, James D Thomas, Robert K Bradley, John K Lee, Emily M Hatch, Marina K Baine, Natasha Rekhtman, Marc Ladanyi, Federica Piccioni, Alice H Berger
Integrative oncogene-dependency mapping identifies RIT1 vulnerabilities and synergies in lung cancer. Nature communications 12 (1) (2021)
Alexis M Thornton, Lishan Fang, April Lo, Maria McSharry, David Haan, Casey OʼBrien, Alice H Berger, Marios Giannakis, Angela N Brooks
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants. PLoS computational biology 17 (7) (2021)
Amanda K Riley, Alice H Berger
Genome-wide CRISPR screening reveals novel therapeutic targets in RIT1-driven lung cancer. Molecular & cellular oncology 8 (6) (2021)
April Lo, Kristin Holmes, Shriya Kamlapurkar, Filip Mundt, Sitapriya Moorthi, Iris Fung, Shaunt Fereshetian, Jacqueline Watson, Steven A Carr, Philipp Mertins, Alice H Berger
Multiomic characterization of oncogenic signaling mediated by wild-type and mutant RIT1. Science signaling 14 (711) (2021)
James D Thomas, Jacob T Polaski, Qing Feng, Emma J De Neef, Emma R Hoppe, Maria V McSharry, Joseph Pangallo, Austin M Gabel, Andrea E Belleville, Jacqueline Watson, Naomi T Nkinsi, Alice H Berger, Robert K Bradley
RNA isoform screens uncover the essentiality and tumor-suppressor activity of ultraconserved poison exons. Nature genetics 52 (1) (2020)

Alice H Berger.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Alice H Berger